View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Decisions of KH Group’s Annual General Meeting and the constitutive me...

Decisions of KH Group’s Annual General Meeting and the constitutive meeting of the Board of Directors KH Group PlcStock Exchange release 7 May 2024 at 3:20 pm EEST Decisions of KH Group’s Annual General Meeting and the constitutive meeting of the Board of Directors KH Group Plc’s Annual General Meeting was held on 7 May 2024 at KH Group’s headquarters at the address Kuninkaalantie 19, 01300 Vantaa, Finland. The Annual General Meeting supported all the proposals included in the notice of the Annual General Meeting. The General Meeting adopted the financial statements for the financial peri...

 PRESS RELEASE

KH Groupin varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskok...

KH Groupin varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset KH Group OyjPörssitiedote 7.5.2024 klo 15.20 KH Groupin varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset KH Group Oyj:n varsinainen yhtiökokous pidettiin 7.5.2024 KH Groupin pääkonttorissa osoitteessa Kuninkaalantie 19, 01300 Vantaa. Yhtiökokous kannatti kaikkia yhtiökokouskutsuun sisältyneitä ehdotuksia. Yhtiökokous vahvisti tilinpäätöksen tilikaudelta 2023, myönsi hallituksen jäsenille ja toimitusjohtajana toimineille henkilöille vastuuvapauden tilikaudelta 2023 ja vahvisti...

Groupe Parot: 1 director

A director at Groupe Parot maiden bought 4,984,436 shares at 8.830EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Greenworks (Jiangsu) Co Ltd: 1 director

A director at Greenworks (Jiangsu) Co Ltd bought 300,000 shares at 15.200CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Shandong Dongyue Organosilicon Materials Co Ltd: 1 director

A director at Shandong Dongyue Organosilicon Materials Co Ltd bought 50,000 shares at 7.850CNY and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...

Zhejiang Narada Power Source Co Ltd: 3 directors

Three Directors at Zhejiang Narada Power Source Co Ltd bought/maiden bought 59,800 shares at between 10.370CNY and 10.380CNY. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...

Jiangxi Fushine Pharmaceutical Co Ltd: 1 director

A director at Jiangxi Fushine Pharmaceutical Co Ltd bought 604,700 shares at 10.360CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

 PRESS RELEASE

Power Integrations to Acquire the Assets of Odyssey Semiconductor

SAN JOSE, Calif.--(BUSINESS WIRE)-- Power Integrations (NASDAQ: ), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced an agreement to acquire the assets of Odyssey Semiconductor Technologies (OTCQB: ODII), a developer of vertical gallium-nitride (GaN) transistor technology. The transaction is expected to close in July 2024, after which all key Odyssey employees are expected to join Power Integrations’ technology organization. The acquisition supports the company’s ongoing development roadmap for its proprietary PowiGaN™ technology, which is ...

 PRESS RELEASE

Silynxcom and 3M PELTOR Further Collaborate for Latest Innovative Solu...

Silynxcom and 3M PELTOR Further Collaborate for Latest Innovative Solution, the ComTac™ VIII Headset Netanya, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices as well as other communication accessories, announced the expansion of its ongoing collaboration with 3M™ PELTOR™ ("Peltor"). Peltor is recognized as a global leading manufacturer of over-the-ear headsets. Known for its commitment to innovation and quality, Peltor's products are designe...

 PRESS RELEASE

Alliance Trust PLC - Net Asset Value

Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC                 At the close of business Friday 03 May 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 1254.6p                 -       including income, 1261.1p   The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income, 1259.4p -       including income, 1265.9p For further information, please contact: -  Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in acc...

 PRESS RELEASE

EQS-News: Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennu...

Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort(e): Konferenz Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024 07.05.2024 / 14:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024 Die Studiendaten von eAArly DETECT belegten eine Sensitivität für Darmkrebs von 97% mit einer Spezifität von 97% und eine Sensitivität für fortgeschrittene Adenom...

 PRESS RELEASE

EQS-News: Mainz Biomed to Present Results of Colorectal Cancer Screeni...

Issuer: Mainz BioMed N.V. / Key word(s): Conference Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. 07.05.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELE...

 PRESS RELEASE

EQS-News: Mynaric selected by Rocket Lab for Space Development Agency’...

EQS-News: Mynaric AG / Key word(s): Incoming Orders Mynaric selected by Rocket Lab for Space Development Agency’s Tranche 2 Transport Layer – Beta Program 07.05.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Laser Communications Manufacturer Expands Customer Roster  LOS ANGELES, May 7, 2024 –  (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced that it has been selected by Rocket Lab USA, Inc (NASDAQ: RKLB) to supply free space optical ...

 PRESS RELEASE

EQS-News: Mynaric wurde von Rocket Lab für das Tranche 2 Transport Lay...

EQS-News: Mynaric AG / Schlagwort(e): Auftragseingänge Mynaric wurde von Rocket Lab für das Tranche 2 Transport Layer - Beta Programm der Space Development Agency ausgewählt 07.05.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hersteller für Laserkommunikation erweitert Kundenstamm   LOS ANGELES, 7. Mai 2024 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), ein führender Großserienanbieter von kosteneffektiven und in skalierbaren Mengen produzierten Laserkommunikationsprodukten, gab heute bekannt, dass es von Rocket Lab USA, Inc. (...

 PRESS RELEASE

Hitachi Energy supports long-term operation of largest HVDC-connected ...

Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S. Multi-year agreement provides service solutions to the SunZia Transmission Project, linking New Mexico’s wind farms to Arizona’s grid, increasing renewable energy to Western States Zurich, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Hitachi Energy announced that it has signed a multi-year agreement with Pattern Energy to support its high-voltage direct current (HVDC) technologies for the SunZia Transmission Project. The link will connect the 3,515-megawatt (MW) SunZia Wind project in New ...

 PRESS RELEASE

Interim report for Q2 and H1 2023/24 (the period 01.10.2023 - 31.03.20...

Interim report for Q2 and H1 2023/24 (the period 01.10.2023 - 31.03.2024) Nørresundby, Denmark, 7 May 2024Announcement no. 25/2024 Q2 MEETS EXPECTATIONS, WITH GROWING ORDERS AND SALES, IN A MARKET, WHERE CUSTOMER INVENTORIES ARE NORMALIZING AND REORDERING IS BEGINNING TO PICK UP. “The results for Q2 are in line with our expectations for the quarter, reaching sales of DKK 125 million and trimming inventory by DKK 8 million during the quarter. In Q2, we furthermore see an increase in our order intake, indicating a shift towards more typical market dynamics, characterized by shorter ...

Roelof-Jan van den Akker
  • Roelof-Jan van den Akker

Technical Analysis/Cocoa

The daily chart worsened significantly last week, violating our bullish view we communicated in the previous updates in combination with the bullish target for US$13,265/MT. This suggests that prices have topped within the accelerating move since the breakout above US$4,275/MT mid-January.

 PRESS RELEASE

Bridger Aerospace Announces Schedule for its First Quarter 2024 Earnin...

Bridger Aerospace Announces Schedule for its First Quarter 2024 Earnings Release and Conference Call BELGRADE, Mont., May 07, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced that it will release financial results for the first quarter ended March 31, 2024 on Monday, May 13, 2024 after the market close. Management will conduct an investor conference call on Monday, May 13, 2024, at 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time) to discus...

 PRESS RELEASE

Form 8.3 - UK Commercial Property REIT Limited

Form 8.3 - UK Commercial Property REIT Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securitie...

 PRESS RELEASE

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® ...

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that additional data supporting IBSRELA® (tenapanor) will be presented at the 2024 Digestive Disease Week Conference (DDW), to be held May 18-2...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch